Is There a Difference Between Medial and Lateral Femoral Condyle Allografts? An Outcome and Survivorship Analysis Authors: Bryan D Bourland, Roslyn M Kackman, Jordan K Penn, William D Bugbee, Tim Wang Published: 2026 ABSTRACT AbstractBackground:Focal chondral and osteochondral defects in the knee are often difficult to treat. One solution is the use of osteochondral allograft (OCA) transplantation. The literature deliberates lesions located in the medial femoral condyle (MFC), but little is discussed regarding the lateral femoral condyle (LFC).Purpose:To compare graft survivorship and patient-reported outcomes (PROs) among patients who underwent OCA transplantation of the LFC to the MFC.Study Design:Cohort study; Level of evidence, 3.Methods:A total of 319 patients who underwent primary OCA transplantation of the LFC (n = 111) and MFC (n = 208) were identified. Reoperations were recorded, and OCA failure was defined as allograft removal. PROs included the Knee injury and Osteoarthritis Outcomes Score (KOOS), the International Knee Documentation Committee (IKDC) score, the modified Merle d’Aubigné-Postel score, and satisfaction.Results:Patients with MFC grafts were older than those with LFC grafts (33 and 26 years, respectively; P < .001) and had a slightly higher body mass index (25.6 and 24.4 kg/m2, respectively; P = .039). Diagnosis, sex, and allograft size did not differ between groups. Reoperations occurred in 27.9% of MFC grafts and 26.1% of LFC grafts (P = .737). OCA failure occurred in 12% of MFC grafts and 9% of LFC grafts (P = .413). The 10-year survivorship was 88% for MFC grafts and 92.9% for LFC grafts (P = .543). Among in situ allografts, the mean follow-up duration was 9.4 years for MFC grafts and 8.6 years for LFC grafts (P = .313). At the latest follow-up, the IKDC pain subscale and total scores were similar, but function subscale scores differed significantly between LFC (6.8 ± 2.4) and MFC (7.5 ± 2.1) patients (P = .019). KOOS and Merle d’Aubigné-Postel scores were similar between patients with MFC and LFC grafts. Patients with MFC grafts reported higher satisfaction than those with LFC grafts (93.7% vs 86.3%, respectively; P = .041).Conclusion:OCA transplantation of the LFC demonstrates high graft survivorship and significant improvement in PROs at mid-term follow-up. Clinical outcomes, reoperation rates, and survivorship were comparable to OCA transplantation of the MFC. These findings suggest that OCA transplantation of the LFC represents a reliable treatment option in appropriately selected patients.Keywords: allografts, articular cartilage repair, knee, osteochondral allograft transplantation Chondral and osteochondral lesions of the knee can present as devastating injuries to patients, limiting mobility and quality of life. Articular injuries of the knee are frequently seen in the younger demographic, with a prevalence of 36% during knee arthroscopy. 11 The medial femoral condyle (MFC) is the most common location in the knee for these lesions, followed by the patella. 1 These cartilage injuries can progress to further degenerative osteoarthritis, with 50% of significant knee injuries developing arthritis at 10 to 20 years. 18 Articular cartilage has poor healing potential, and thus a variety of cartilage restoration techniques have been developed to treat focal articular cartilage damage. Current recommendations for the management of articular cartilage injuries take into account the specific location of the defect, as well as its size and depth.5,15,16,20 Multiple strategies include subchondral marrow stimulation, autologous chondrocyte implantation, osteochondral autograft transplantation, and fresh osteochondral allograft (OCA) transplantation. Fresh OCA transplantation is advantageous for its single-stage nature, predictable bone-to-bone healing, and ability to treat cartilage injuries of varying sizes and depths in both the primary and revision settings. Furthermore, it is an effective joint preservation procedure, with reported survivorship of 80% at 10 years postoperatively3,17 and a return to sport 7 of over 75%. Additionally, OCA yields predictable improvements in patient-reported outcomes (PROs), with a meta-analysis 6 showing an aggregate International Knee Documentation Committee (IKDC) score improvement of 39.6, far greater than the minimal clinically important difference 22 (MCID) of 26.9. While there is robust literature supporting OCA transplantation for articular cartilage damage, many studies predominantly report outcomes from the medial compartment or multiple compartments of the knee,2,12,14,26 and there is a paucity of published studies regarding the lateral compartment of the knee. Given the numerous anatomic and biomechanical differences between the medial and lateral compartments, it may not be appropriate to extrapolate data from MFC OCAs to lateral femoral condyle (LFC) OCA outcomes. In particular, the MFC is oval with longer anteroposterior length, whereas the LFC is circular, flatter, and has a lower radius of curvature. 8 The medial tibial plateau has a more concave morphology akin to a “ball and socket” joint. In contrast, the lateral tibial plateau is more convex and has a larger meniscal surface area. Biomechanically, greater load is passed through the medial compartment, particularly during single-leg stance, whereas the lateral compartment is subject to greater translational/sliding forces. 4 Technically speaking, OCA transplantation of the LFC can be more challenging due to less frequently seen pathology, lack of surgeon familiarity with the surgical approach, and difficulty accessing large posterolateral lesions. Given the relative infrequency of LFC chondral lesions, few studies have reported on the outcomes of LFC OCA transplantations, and these studies are often published alongside heterogeneous patient cohorts. Therefore, this study aimed to evaluate graft survivorship and PROs in patients treated with isolated LFC osteochondral allografts and to compare these outcomes with those of a reference group of patients receiving MFC OCA transplantation. We hypothesized that patients with LFC OCA would have acceptable graft survivorship and improved postoperative outcomes, and that patients with LFC would be comparable to patients with MFC OCA. Methods Patient Population An institutional review board (IRB)-approved registry of patients undergoing OCA transplantation of the knee (IRB No.13-6297) was used to identify patients. All patients provided informed consent to participate in the registry, and data were collected prospectively. Surgical indications for OCA transplantation included isolated International Cartilage Repair Society Grade III or IV chondral or osteochondral lesions with persistent symptoms that were not alleviated by nonsurgical treatment. The inclusion criteria included patients undergoing primary OCA transplantation of the MFC or LFC between 1997 and 2021, with a minimum 2-year follow-up. Patients with multifocal OCA transplantation (>1 anatomic location) or previous OCA transplantation were excluded. Follow-up Data Collection Reoperations after the OCA transplantation were recorded. OCA failure was defined as removal of the allograft (revision OCA transplantation or conversion to arthroplasty). Patient-reported outcomes (PROs) were completed by patients preoperatively and postoperatively at each follow-up visit. Patients living outside the local area were sent a follow-up questionnaire via mail. Additionally, patients who had not had a recent follow-up were mailed a questionnaire to obtain a current follow-up. PROs included the IKDC score, Knee injury and Osteoarthritis Outcome Score (KOOS), and a modified Merle d’Aubigné-Postel score. Additionally, patient satisfaction was evaluated on a 5-point Likert scale, with responses ranging from dissatisfied to extremely satisfied. Responses of “satisfied” or “extremely satisfied” were used to classify patients as satisfied with surgery. Data from each patient's latest follow-up were used in the present analysis. Surgical Technique Fresh OCA transplantation was performed by the senior author (W.D.B.) using the thin plug technique as previously described. 26 In brief, a medial or lateral parapatellar approach was used to expose the corresponding femoral condyle. The articular defect was measured and drilled with an appropriately sized reamer to a depth of 5 to 8 mm. The corresponding cylindrical reamer was used on the donor graft to harvest a matching osteochondral bone plug. The donor bone plug was then gently inserted into the defect using a press-fit dowel technique to match the contour of the surrounding articular cartilage. Statistical Analyses Patient and graft characteristics (sex, age, body mass index [BMI], diagnosis, number of grafts, total graft area, concomitant procedure at time of OCA) were described using frequencies for categorical variables and means and standard deviations for continuous variables. Continuous variables were assessed for normality using Shapiro-Wilk tests and visual inspection of histograms and Q-Q plots. Differences between groups were assessed using chi-square tests and independent samples t tests. The frequency of reoperations and OCA failures was compared between groups using chi-square tests. Kaplan-Meier survivorship curves were calculated for each group and compared using the log-rank test. PROMs were described using means and standard deviations, and groups were compared using independent samples t tests. An alpha level of .05 was used to determine significance, and all tests were 2-tailed. Results Using our IRB-approved allograft registry, we identified 403 patients who underwent an OCA transplantation of the femoral condyle between 1997 and 2021. Of those, 319 patients (111 LFC and 208 MFC) met the inclusion criteria and were included in the study (Figure 1). Patient population flowchart. LFC, lateral femoral condyle; MFC, medial femoral condyle; OCA, osteochondral allograft. Patients with LFC grafts were younger than those with MFC grafts (26 and 32.9 years, respectively; P < .001) and had a slightly lower BMI (24.4 and 25.6 kg/m2, respectively; P = .039). There were no differences between groups in sex, diagnosis, number of allografts transplanted, or total allograft surface area (Table 1). Concomitant procedures were performed in 38 (34.2%) patients with LFC and 53 (25.5%) patients with MFC (Table 2). Table 1Patient and Graft Characteristics a LFCMFC P Sex.290 Female34 (31)76 (37) Male77 (69)132 (63)Age, years26 ± 9.732.9 ± 12.6 <.001 BMI, kg/m224.4 ± 425.6 ± 4.9 .039 Diagnosis.443 Avascular necrosis13 (12)21 (10) Degenerative chondral lesion18 (16)33 (16) Fracture5 (5)2 (1) Osteoarthritis4 (4)10 (5) Osteochondral dissecans60 (53)121 (58) Traumatic chondral injury11 (10)21 (10)Number of grafts <.001 195 (86)133 (64) 216 (14)71 (34) 304 (2)Total graft area, cm26.8 ± 2.36.6 ± 2.6.589aData are presented as mean ± SD or n (%). Bold P values indicate statistical significance. P values for group comparisons were calculated using the chi-square test or the independent-samples t test. BMI, body mass index; LFC, lateral femoral condyle; MFC, medial femoral condyle. Patient and Graft Characteristics a Data are presented as mean ± SD or n (%). Bold P values indicate statistical significance. P values for group comparisons were calculated using the chi-square test or the independent-samples t test. BMI, body mass index; LFC, lateral femoral condyle; MFC, medial femoral condyle. Table 2Concomitant Procedures with OCA Transplantation a LFCMFC P Concomitant procedure32 (28.8)53 (25.5).519List of procedures b ACLR1116 Arthroscopic debridement411 Bone graft11 Curette of cyst01 Drilling14 DFO71 HTO018 Hardware removal48 Meniscectomy85 Meniscus repair31 Meniscal allograft transplantation50 Microfracture of the tibia11 MPFLR10 Neuroma excision01 Physeal stapling of the distal femur10 Retinacular release/advancement32aData are presented as occurrences (percentage of procedure list). P value for group comparison was calculated using the chi-square test. ACLR, anterior cruciate ligament reconstruction; DFO, distal femoral osteotomy; HTO, high tibial osteotomy; LFC, lateral femoral condyle; MFC, medial femoral condyle; MPFLR, medial patellofemoral ligament reconstruction; OCA, osteochondral allograft.bSome patients had >1 concomitant procedure. Concomitant Procedures with OCA Transplantation a Data are presented as occurrences (percentage of procedure list). P value for group comparison was calculated using the chi-square test. ACLR, anterior cruciate ligament reconstruction; DFO, distal femoral osteotomy; HTO, high tibial osteotomy; LFC, lateral femoral condyle; MFC, medial femoral condyle; MPFLR, medial patellofemoral ligament reconstruction; OCA, osteochondral allograft. Some patients had >1 concomitant procedure. Reoperations were not different between patients with LFC grafts and MFC grafts, occurring in 26.1% of patients with LFC grafts and 27.9% of patients with MFC grafts (P = .737) (Table 3). Similarly, OCA failure rates did not differ between patients with LFC grafts (9%) and patients with MFC grafts (12%) (P = .413). The 5-, 10-, and 15-year survivorship was 95.2%, 92.9%, and 82.8%, respectively, for LFC grafts, and 93%, 88%, and 82.5%, respectively, for MFC grafts (P = .543) (Figure 2). Table 3Reoperations After OCA Transplantation a LFCMFC P Further surgery29 (26.1)58 (27.9).737List of surgeries b Diagnostic scope11 (9.9)16 (7.7) Debridement4 (3.6)9 (4.3) Loose body removal1 (0.9)4 (1.9) Osteotomy1 (0.9)1 (0.5) DFO4 (3.6)0 Meniscectomy4 (3.6)3 (1.4) Meniscus repair4 (3.6)4 (1.9) Synovectomy2 (1.8)4 (1.9) Chondroplasty2 (1.8)2 (0.9) Scar tissue removal1 (0.9)1 (0.5) Hardware removal3 (2.7)6 (2.9)Classified as an OCA failure UKA1 (0.9)8 (3.8) TKA3 (2.7)11 (5.3) OCA revision6 (5.4)7 (3.4)aData are presented as occurrence (percentage). P value for group comparison was calculated using the chi-square test. DFO, distal femoral osteotomy; LFC, lateral femoral condyle; MFC, medial femoral condyle; OCA, osteochondral allograft; TKA, total knee arthroplasty; UKA, unicompartmental knee arthroplasty.bSome patients had >1 further surgery or procedure. Reoperations After OCA Transplantation a Data are presented as occurrence (percentage). P value for group comparison was calculated using the chi-square test. DFO, distal femoral osteotomy; LFC, lateral femoral condyle; MFC, medial femoral condyle; OCA, osteochondral allograft; TKA, total knee arthroplasty; UKA, unicompartmental knee arthroplasty. Some patients had >1 further surgery or procedure. Kaplan-Meier curve of LFC and MFC OCA transplantation survivorship. LFC, lateral femoral condyle; MFC, medial femoral condyle; OCA, osteochondral allograft. Among the 101 patients with LFC grafts and 182 with MFC grafts who had the allograft in situ at the latest follow-up, the mean follow-up duration was 9.4 years for MFC grafts and 8.6 years for LFC grafts (P = .313). Patients with MFC grafts had higher baseline total IKDC scores (P = .044) and IKDC pain scores (P = .011), and higher IKDC function at the latest follow-up (P = .019). KOOS and Merle d’Aubigné-Postel scores were comparable between groups at preoperative and latest follow-up (Table 4). At the latest follow-up, patients receiving MFC grafts showed greater improvements in total IKDC score, IKDC function, and pain subscores (all P < .005). In contrast, improvements in KOOS and Merle d’Aubigné-Postel scores were similar between patients with MFC and LFC grafts (Figure 3). Table 4PROs at Preoperative and Latest Follow-up a LFCMFC P IKDC Pain preop5 ± 2.55.8 ± 2.4 .011 Pain postop3.2 ± 2.62.8 ± 2.5.192 Function preop3.6 ± 1.93.3 ± 1.6.128 Function postop6.8 ± 2.47.5 ± 2.1 .019 Total preop46.3 ± 18.841.5 ± 15 .044 Total postop71.8 ± 20.975.4 ± 19.8.169KOOS Symptoms preop62.7 ± 18.165.9 ± 18.1.286 Symptoms postop79.8 ± 17.782.1 ± 18.2.377 Pain preop68 ± 19.166.6 ± 17.8.641 Pain postop84.4 ± 17.987.1 ± 16.6.260 ADL preop77.9 ± 18.475.4 ± 19.3.424 ADL postop89.9 ± 15.892.5 ± 14.4.210 Sport/rec Preop40.1 ± 25.538.2 ± 25.8.677 Sport/rec postop70.1 ± 29.772.6 ± 26.1.541 QoL preop26.8 ± 1926.5 ± 19.3.922 QoL postop61.6 ± 24.966.8 ± 25.1.138Merle d’Aubigné-Postel, 18-point Preop13.7 ± 2.413.2 ± 1.9.140 Postop16 ± 2.216.2 ± 2.1.542aData presented as means ± standard deviations. P values for group comparisons were calculated using the independent-samples t test.ADL, activities of daily life; IDKC, International Knee Documentation Committee; KOOS, Knee injury and Osteoarthritis Outcome Score; LFC, lateral femoral condyle; MFC, medial femoral condyle; Postop, postoperative; Preop, preoperative; PROs, patient-reported outcomes; QoL, quality of life; Sport/Rec, sports and recreation. PROs at Preoperative and Latest Follow-up a Data presented as means ± standard deviations. P values for group comparisons were calculated using the independent-samples t test. ADL, activities of daily life; IDKC, International Knee Documentation Committee; KOOS, Knee injury and Osteoarthritis Outcome Score; LFC, lateral femoral condyle; MFC, medial femoral condyle; Postop, postoperative; Preop, preoperative; PROs, patient-reported outcomes; QoL, quality of life; Sport/Rec, sports and recreation. Change in patient-reported outcome scores from preoperative to latest follow-up. ADL, activities of daily life; IDKC, International Knee Documentation Committee; KOOS, Knee injury and Osteoarthritis Outcome Score; LFC, lateral femoral condyle; MFC, medial femoral condyle; QoL, quality of life; Sport/Rec, sports and recreation. Patients with MFC grafts reported higher satisfaction than those with LFC grafts (93.7% vs 86.3%, respectively; P = .041). Discussion We report high overall graft survivorship and improved PROs in patients treated with isolated LFC OCA transplantation, with outcomes comparable to those observed with MFC OCA transplantation. Although patients undergoing LFC transplantation were younger and had lower BMIs than those undergoing MFC transplantation, graft survivorship, reoperation rates, and most PRO improvements were similar across compartments. OCA transplantation of the LFC can be more challenging due to less frequently encountered pathology and difficulty accessing lateral and posterolateral lesions, but we report overall positive outcomes after OCA transplantation in the lateral compartment, with results comparable to those in the medial compartment. Despite an abundance of literature on osteochondral lesions of the knee, there is little focused specifically on the LFC. Although physicians may extrapolate medial compartment data to lateral compartment lesions, few reports exist on cartilage performed specifically in the lateral compartment. 24 We were unable to identify any articles directly comparing outcomes of cartilage treatment of the lateral compartment to the medial compartment. Tirico et al 26 demonstrated a survivorship of 91.2% for femoral condyle lesions treated with OCA at 10 years postoperatively, with MFC allografts composing 69% of cases. Sadr et al 23 reported a series of patients undergoing OCA transplantation for OCD lesions, where 62% of lesions were in the MFC and 29% in the LFC. Other published studies on OCA of the LFC are limited to case reports only.19,24 A recent article by Ebert et al 10 reported 10-year outcomes of MACI performed in the tibiofemoral joint and found a 10.8% failure rate, with treatment of MFC defects 2.6 times more common than LFC defects. Duporté et al 9 reported positive outcomes in a series of LFC defects treated with osteochondral autograft transfer, with the most common causes being osteochondritis dissecans (OCD) and osteochondral fractures. Some authors have looked at the differences in orthotopic versus nonorthotopic OCA transplantation (LFC donor to MFC recipient, or vice versa) and have found similar appearance in subchondral bone step-off and surface match21,25 and similar clinical outcomes. 27 Although we identified statistically significant differences in IKDC score improvement between LFC and MFC groups, this difference did not meet the MCID threshold for IKDC of 9.8 points or the substantial clinical benefit threshold of 26.9 points. 22 Our data showed that 2 plugs were more frequently used in MFC lesions than in LFC lesions, despite similar total graft size. This likely reflects anatomical differences in condylar geometry, as the MFC is typically longer and narrower in the anteroposterior dimension, often requiring 2 plugs to recreate lesion morphology. In contrast, the LFC is more circular, and lesions are more commonly similar in anteroposterior and mediolateral dimensions, making them amenable to a single plug. Previous literature has demonstrated that the number of plugs does not independently affect clinical outcomes. 28 Causes of lateral knee lesions may differ from those of the medial compartment. We found that patients receiving MFC grafts were, on average, 7 years older than patients receiving LFC grafts. Although this may suggest a more likely degenerative-type cause in medial lesions, we did not find this to be the case when evaluating primary diagnosis. Garret et al 13 reported 15% of OCD lesions of the femur are located in the lateral compartment. While the lower age and BMI we found in our patients with LFC may have biased our results toward better clinical outcomes, LFC and MFC survivorship and outcomes were similar. Although differences in alignment, meniscal status, and loading patterns may theoretically influence compartment-specific degeneration, our findings demonstrate that when treated with OCA transplantation, survivorship and clinical improvements are comparable between compartments. This study has several limitations. First, it is a retrospective analysis of prospectively collected registry data and is therefore subject to confounding and selection bias. Another limitation of this study was that an a priori power analysis was not performed due to the low incidence of our primary outcome, OCA failure. Given the low failure rate, a sample size substantially larger than that available in our institutional registry would be required to power comparisons between MFC and LFC grafts adequately. Additionally, heterogeneity in lesion cause, the number of grafts, and the rates of concomitant procedures between patients with LFC and MFC may have influenced outcomes. Finally, this study reflects the experience of a high-volume cartilage surgeon at a single institution, which may limit generalizability. Nevertheless, the present cohort of 319 patients represents a comparatively large series evaluating MFC versus LFC OCA transplantations with mid-term follow-up and provides clinically relevant outcomes data in an area where the existing literature remains limited. Conclusion OCA transplantation of the LFC demonstrates high graft survivorship and significant improvement in PROs at mid-term follow-up. Clinical outcomes, reoperation rates, and survivorship were comparable to OCA transplantation of the MFC. These findings suggest that OCA transplantation of the LFC represents a reliable treatment option in appropriately selected patients. Footnotes Final revision submitted March 2, 2026; accepted March 19, 2026. One or more of the authors has declared the following potential conflict of interest or source of funding: W.D.B. has received consulting fees from Arthrex, DePuy, Enovis, Icarus Medical, JRF Ortho, Orthalign, Overture, and Smith & Nephew; royalties from Orthalign and Smith & Nephew; and holds stock or stock options in Icarus Medical and Orthalign. T.W. has received consulting fees from Arthrex and Moximed; research support from Miach Othopaedics and Smith & Nephew; and holds stock or stock options in Overture Orthopaedics. Ethical approval for this study was obtained from Scripps Institutional Review Board (IRB No. 13-6297). ORCID iDs: William D. Bugbee https://orcid.org/0000-0002-4250-6849 Tim Wang https://orcid.org/0000-0002-5103-6674 References